A company has priced its test for mutations linked to breast and ovarian cancer at $249 — far less than the thousands of dollars another firm charges. But is there a downside for the worried well?
A company has priced its test for mutations linked to breast and ovarian cancer at $249 — far less than the thousands of dollars another firm charges. But is there a downside for the worried well?